ImmTOR™ Gene Therapy: Publications & Posters
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector readministration
Meliani A, Boisgerault F, Hardet R, et al.
Preferential Trafficking to Liver Parenchyma Cells and Tolerogenic Signal Induction by ImmTOR™ Nanoparticles Leads to Higher AAV Vector Transduction and Transgene Expression after Initial and Repeat Administrations
Petr Ilyinskii, Chris Roy, Alicia Michaud, Gina Rizzo, Stephanie Elkins, Teresa Capela, Aparajita Chowdhury, Sheldon Leung, and Takashi Kei Kishimoto
Tolerogenic ImmTOR™ nanoparticles enhance vector transduction, mRNA synthesis and transgene expression after initial and repeated administrations of AAV-based gene therapy vectors
Ilyinskii P, et al.
Mitigation of inflammation induced by monosodium urate crystals in mice by treatment with SVP-rapamycin
Pallavi Kolte, Robert LaMothe, Joseph Ferrari, Sheldon Leung, Wesley DeHaan, Earl Sands, and Takashi Kei Kishimoto
Antigen-specific modulation of capsid immunogenicity with tolerogenic nanoparticles results in successful AAV vector readministration
Takashi Kei Kishimoto, Amine Meliani, Fanny Collaud, Christian Leborgne, Ronzitti Guiseppe, Florence Boisgerault, and Federico Mingozzi